New York joins state lawsuits over Vioxx FDA Approves Levaquin Short-Course Therapy Treatment Appeals court rules in favor of Novartis; stops Teva from selling generic Famvir for now Eli Lilly settles with whistleblower for $100,000 Chephalon warns Fentora prescribers about possible adverse effects Industry, health groups’ alarm grows as tamper-proof deadline approaches Chephalon finalizes label revisions for Provigil Bayer Schering completes acquisition of Novartis' facility Target offers flavored medications for kids FDA approves new dosage of MedPointe's Soma First Previous 1411 1412 1413 1414 1415 Next Last
